Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors.
Year: 2015
Type: review
Abstract: Immune checkpoint inhibitors are increasingly drawing much attention in the therapeutic development for cancer treatment. However, many cancer patients do not respond to treatments with immune checkpoint inhibitors, partly because of the lack of tumor-infiltrating effector T cells. Cancer vaccines may prime patients for treatments with immune checkpoint inhibitors by inducing effector T-cell infiltration into the tumors and immune checkpoint signals. The combination of cancer vaccine and an immune checkpoint inhibitor may function synergistically to induce more effective antitumor immune responses, and clinical trials to test the combination are currently ongoing.
Source: PubMed Central
Authors: Jennifer Kleponis, Richard Skelton, Lei Zheng
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer, Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro, SPORE in Gastrointestinal Cancers, Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
OpenAlex ID: W1958471581
